Literature DB >> 16126884

Congenital dermatofibrosarcoma protuberans with fibrosarcomatous and myxoid change.

W Gu1, A Ogose, H Kawashima, H Umezu, N Kudo, T Hotta, N Endo.   

Abstract

This report describes a case of congenital dermatofibrosarcoma protuberans (DFSP) with fibrosarcomatous (FS) and myxoid areas. Immunohistochemical results showed that tumour cells in ordinary DFSP areas were diffusely positive for CD34, whereas in the FS and myxoid areas, few tumour cells were positive for this antigen. Ki-67 positive tumour cell numbers were greater in the FS (11.8%) and myxoid areas (19.8%) relative to ordinary DFSP areas (2.2%). Reverse transcription polymerase chain reaction and sequence analysis showed the presence of an identical COL1A1-PDGFB fusion transcript in ordinary DFSP (plaque-like area), FS, and myxoid areas of DFSP. These results indicate that the three components of DFSP have a common histogenesis. This study documents the first application of gene analysis involving the myxoid area of DFSP.

Entities:  

Mesh:

Year:  2005        PMID: 16126884      PMCID: PMC1770823          DOI: 10.1136/jcp.2004.024430

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

1.  COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans.

Authors:  J Wang; Y Morimitsu; S Okamoto; M Hisaoka; T Ishida; W Sheng; H Hashimoto
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

2.  Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.

Authors:  T Mentzel; A Beham; D Katenkamp; A P Dei Tos; C D Fletcher
Journal:  Am J Surg Pathol       Date:  1998-05       Impact factor: 6.394

Review 3.  Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment.

Authors:  Nicolas Sirvent; Georges Maire; Florence Pedeutour
Journal:  Genes Chromosomes Cancer       Date:  2003-05       Impact factor: 5.006

4.  Congenital dermatofibrosarcoma protuberans: variability in presentation.

Authors:  Jill M Weinstein; Beth A Drolet; Nancy B Esterly; Maureen Rogers; Bruce S Bauer; Annette M Wagner; Anthony J Mancini
Journal:  Arch Dermatol       Date:  2003-02

5.  CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma.

Authors:  J R Goldblum; R J Tuthill
Journal:  Am J Dermatopathol       Date:  1997-04       Impact factor: 1.533

Review 6.  Involvement of chromosomes 17 and 22 in dermatofibrosarcoma protuberans.

Authors:  F Minoletti; M Miozzo; F Pedeutour; L Sard; S Pilotti; A Azzarelli; C Turc-Carel; M A Pierotti; G Sozzi
Journal:  Genes Chromosomes Cancer       Date:  1995-05       Impact factor: 5.006

  6 in total
  2 in total

1.  Transformed dermatofibrosarcoma protuberans: real time polymerase chain reaction detection of COL1A1-PDGFB fusion transcripts in sarcomatous areas.

Authors:  Zoltan Szollosi; Beata Scholtz; Kristof Egervari; Zoltan Nemes
Journal:  J Clin Pathol       Date:  2006-05-26       Impact factor: 3.411

2.  Dermatofibrosarcoma protuberans: A case report of a rare, bulky tumor that was managed with surgical therapy.

Authors:  Ahmet Yılmaz; Erol Cenesizoglu; Ertuğrul Eğilmez; Safa Onel; Mehdi Muştu; Ahmet Cennet
Journal:  Int J Shoulder Surg       Date:  2009-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.